[1]
|
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Placenta;
PubMed=8397373 [NCBI, ExPASy, EBI, Israel, Japan]
ten Dijke P.,
Ichijo H.,
Franzen P.,
Schulz P.,
Saras J.,
Toyoshima H.,
Heldin C.-H.,
Miyazono K.;
"Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity.";
Oncogene 8:2879-2887(1993).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Kidney;
PubMed=8196624 [NCBI, ExPASy, EBI, Israel, Japan]
Carcamo J.,
Weis F.M.,
Ventura F.,
Wieser R.,
Wrana J.L.,
Attisano L.,
Massague J.;
"Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.";
Mol. Cell. Biol. 14:3810-3821(1994).
|
[3]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND ALTERNATIVE SPLICING.
TISSUE=Liver;
PubMed=8058741 [NCBI, ExPASy, EBI, Israel, Japan]
Xu J.,
Matsuzaki K.,
McKeehan K.,
Wang F.,
Kan M.,
McKeehan W.L.;
"Genomic structure and cloned cDNAs predict that four variants in the kinase domain of serine/threonine kinase receptors arise by alternative splicing and poly(A) addition.";
Proc. Natl. Acad. Sci. U.S.A. 91:7957-7961(1994).
|
[4]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
Kalnine N.,
Chen X.,
Rolfs A.,
Halleck A.,
Hines L.,
Eisenstein S.,
Koundinya M.,
Raphael J.,
Moreira D.,
Kelley T.,
LaBaer J.,
Lin Y.,
Phelan M.,
Farmer A.;
"Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
|
[5]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
TISSUE=Brain, and Eye;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[6]
|
PHOSPHORYLATION AT TYR-380.
DOI=10.1002/1615-9861(200206)2:6<642::AID-PROT642>3.0.CO;2-I; PubMed=12112843 [NCBI, ExPASy, EBI, Israel, Japan]
Maguire P.B.,
Wynne K.J.,
Harney D.F.,
O'Donoghue N.M.,
Stephens G.,
Fitzgerald D.J.;
"Identification of the phosphotyrosine proteome from thrombin activated platelets.";
Proteomics 2:642-648(2002).
|
[7]
|
VARIANT [LARGE SCALE ANALYSIS] LEU-146.
DOI=10.1038/nature05610; PubMed=17344846 [NCBI, ExPASy, EBI, Israel, Japan]
Greenman C.,
Stephens P.,
Smith R.,
Dalgliesh G.L.,
Hunter C.,
Bignell G.,
Davies H.,
Teague J.,
Butler A.,
Stevens C.,
Edkins S.,
O'Meara S.,
Vastrik I.,
Schmidt E.E.,
Avis T.,
Barthorpe S.,
Bhamra G.,
Buck G.,
Choudhury B., ![]()
Clements J.,
Cole J.,
Dicks E.,
Forbes S.,
Gray K.,
Halliday K.,
Harrison R.,
Hills K.,
Hinton J.,
Jenkinson A.,
Jones D.,
Menzies A.,
Mironenko T.,
Perry J.,
Raine K.,
Richardson D.,
Shepherd R.,
Small A.,
Tofts C.,
Varian J.,
Webb T.,
West S.,
Widaa S.,
Yates A.,
Cahill D.P.,
Louis D.N.,
Goldstraw P.,
Nicholson A.G.,
Brasseur F.,
Looijenga L.,
Weber B.L.,
Chiew Y.-E.,
DeFazio A.,
Greaves M.F.,
Green A.R.,
Campbell P.,
Birney E.,
Easton D.F.,
Chenevix-Trench G.,
Tan M.-H.,
Khoo S.K.,
Teh B.T.,
Yuen S.T.,
Leung S.Y.,
Wooster R.,
Futreal P.A.,
Stratton M.R.;
"Patterns of somatic mutation in human cancer genomes.";
Nature 446:153-158(2007).
|
|
ExPASy Home page
SIB Switzerland
